USA - NASDAQ:PRVA - US74276R1023 - Common Stock
The current stock price of PRVA is 23.41 USD. In the past month the price decreased by -3.02%. In the past year, price increased by 10.42%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.32 | 98.35B | ||
| CI | THE CIGNA GROUP | 9.09 | 68.91B | ||
| LH | LABCORP HOLDINGS INC | 16.51 | 21.70B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.88 | 20.61B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 111.76 | 20.20B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.21B | ||
| HIMS | HIMS & HERS HEALTH INC | 76.02 | 9.28B | ||
| DVA | DAVITA INC | 13.02 | 8.59B | ||
| CHE | CHEMED CORP | 19.82 | 6.35B | ||
| RDNT | RADNET INC | 224.58 | 6.22B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 32.91 | 5.95B | ||
| OPCH | OPTION CARE HEALTH INC | 18.92 | 4.57B |
Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,140 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The firm provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
PRIVIA HEALTH GROUP INC
950 N. Glebe Rd., Suite 700
Arlington VIRGINIA US
CEO: Shawn Morris
Employees: 1140
Phone: 15713668850
Privia Health Group, Inc. engages in the provision of healthcare services. The company is headquartered in Arlington, Virginia and currently employs 1,140 full-time employees. The company went IPO on 2021-04-29. The firm collaborates with medical groups, health plans and health systems. The company enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The firm provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
The current stock price of PRVA is 23.41 USD. The price decreased by -0.09% in the last trading session.
PRVA does not pay a dividend.
PRVA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
26 analysts have analysed PRVA and the average price target is 32.19 USD. This implies a price increase of 37.49% is expected in the next year compared to the current price of 23.41.
PRIVIA HEALTH GROUP INC (PRVA) will report earnings on 2026-02-25, after the market close.
ChartMill assigns a technical rating of 5 / 10 to PRVA. When comparing the yearly performance of all stocks, PRVA is one of the better performing stocks in the market, outperforming 70.43% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to PRVA. No worries on liquidiy or solvency for PRVA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months PRVA reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 30% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.89% | ||
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| Debt/Equity | 0 |
26 analysts have analysed PRVA and the average price target is 32.19 USD. This implies a price increase of 37.49% is expected in the next year compared to the current price of 23.41.
For the next year, analysts expect an EPS growth of 53.99% and a revenue growth 15.55% for PRVA